It’s long been the dream of cancer researchers to be able to use the body’s own immune system to combat compromised cancer cells. In recent studies of patients with head and neck cancer, use of the drug nivolumab has pushed this dream close to reality. Patients treated with the drug had over twice the survival rate at the one year mark as patients who received chemotherapy.
- October 12, 2016
- by :